Koers Yield10 Bioscience Inc Nasdaq
Aandelen
US98585K1025
Biotechnologie & Medisch Onderzoek
Omzet 2024 * | 1,2 mln. 1,12 mln. | Omzet 2025 * | 2,6 mln. 2,43 mln. | Marktkapitalisatie | 912K 853K |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -9 mln. -8,41 mln. | Nettowinst (verlies) 2025 * | -11 mln. -10,28 mln. | EV/omzet 2024 * | 0,76 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 0,35 x |
K/w-verhouding 2024 * |
-0,13
x | K/w-verhouding 2025 * |
-0,12
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 0% |
Recentste transcriptie over Yield10 Bioscience Inc
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Oliver Peoples
FOU | Founder | 66 | 01-06-92 |
Charles Haaser
DFI | Director of Finance/CFO | 68 | 01-01-08 |
Kristi Snell
CTO | Chief Tech/Sci/R&D Officer | 56 | 01-01-97 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chairman | 67 | 01-10-06 | |
Richard Hamilton
BRD | Director/Board Member | 61 | 02-03-17 |
Oliver Peoples
FOU | Founder | 66 | 01-06-92 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+40,80% | 53,67 mld. | |
+35,79% | 38,86 mld. | |
-8,05% | 38,76 mld. | |
-8,98% | 27,27 mld. | |
+10,69% | 25,91 mld. | |
-16,21% | 20,29 mld. | |
+31,00% | 12,78 mld. | |
+28,51% | 12,18 mld. | |
-1,67% | 11,96 mld. |